NanoViricides/$NNVC
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About NanoViricides
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.
Ticker
$NNVC
Sector
Primary listing
AMEX
Employees
7
Headquarters
Website
NanoViricides Metrics
BasicAdvanced
$21M
-
-$0.48
1.32
-
Price and volume
Market cap
$21M
Beta
1.32
52-week high
$2.23
52-week low
$0.85
Average daily volume
251K
Financial strength
Current ratio
4.429
Quick ratio
4.307
Profitability
EBITDA (TTM)
-7.776
Management effectiveness
Return on assets (TTM)
-44.02%
Return on equity (TTM)
-77.53%
Valuation
Price to book
1.87
Price to tangible book (TTM)
1.93
Price to free cash flow (TTM)
-2.232
Free cash flow yield (TTM)
-44.80%
Free cash flow per share (TTM)
-0.43
Growth
Earnings per share change (TTM)
-32.82%
3-year earnings per share growth (CAGR)
-7.02%
10-year earnings per share growth (CAGR)
-14.00%
NanoViricides News
AllArticlesVideos
NanoViricides CEO discusses progress of broad-spectrum antiviral candidate NV-387 - ICYMI
Proactive Investors·2 weeks ago
NanoViricides advances broad-spectrum antiviral NV-387 towards Phase II MPox study
Proactive Investors·2 weeks ago
NanoViricides seeks FDA orphan status for MPox drug
Proactive Investors·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for NanoViricides stock?
NanoViricides (NNVC) has a market cap of $21M as of March 07, 2026.
What is the P/E ratio for NanoViricides stock?
The price to earnings (P/E) ratio for NanoViricides (NNVC) stock is 0 as of March 07, 2026.
Does NanoViricides stock pay dividends?
No, NanoViricides (NNVC) stock does not pay dividends to its shareholders as of March 07, 2026.
When is the next NanoViricides dividend payment date?
NanoViricides (NNVC) stock does not pay dividends to its shareholders.
What is the beta indicator for NanoViricides?
NanoViricides (NNVC) has a beta rating of 1.32. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.